Tenaya Therapeutics, Inc.
TNYA
$1.26
-$0.17-11.89%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 71.67M | 88.16M | 61.45M | 79.47M | 99.30M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.99M | 5.10M | 5.09M | 4.46M | 4.32M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 218.00K | 1.23M | 842.00K | 1.40M | 1.41M |
| Total Current Assets | 75.88M | 94.49M | 67.38M | 85.33M | 105.03M |
|
|
|||||
| Total Current Assets | 75.88M | 94.49M | 67.38M | 85.33M | 105.03M |
| Net Property, Plant & Equipment | 41.97M | 44.65M | 47.75M | 50.38M | 53.09M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.31M | 4.81M | 4.82M | 4.87M | 5.06M |
| Total Assets | 122.15M | 143.95M | 119.94M | 140.58M | 163.19M |
|
|
|||||
| Total Accounts Payable | 3.30M | 5.06M | 5.16M | 5.84M | 4.32M |
| Total Accrued Expenses | 5.87M | 5.52M | 7.47M | 6.69M | 8.75M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.83M | 2.79M | 2.78M | 3.01M | 3.36M |
| Total Finance Division Other Current Liabilities | 657.00K | 772.00K | 562.00K | 637.00K | 282.00K |
| Total Other Current Liabilities | 657.00K | 772.00K | 562.00K | 637.00K | 282.00K |
| Total Current Liabilities | 12.65M | 14.15M | 15.98M | 16.18M | 16.71M |
|
|
|||||
| Total Current Liabilities | 12.65M | 14.15M | 15.98M | 16.18M | 16.71M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 9.38M | 10.12M | 10.83M | 11.53M | 12.21M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 293.00K | 287.00K | 281.00K | 276.00K | 266.00K |
| Total Liabilities | 22.32M | 24.56M | 27.09M | 27.98M | 29.19M |
|
|
|||||
| Common Stock & APIC | 664.39M | 660.68M | 607.24M | 603.10M | 599.01M |
| Retained Earnings | -564.56M | -541.28M | -514.41M | -490.58M | -464.94M |
| Treasury Stock & Other | -1.00K | -10.00K | 28.00K | 76.00K | -67.00K |
| Total Common Equity | 99.83M | 119.40M | 92.85M | 112.60M | 134.00M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 99.83M | 119.40M | 92.85M | 112.60M | 134.00M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 99.83M | 119.40M | 92.85M | 112.60M | 134.00M |
|
|
|||||